Traduction de «results and measures » (Néerlandais → Français) :

Some achievements and figures for the Veterinary Medicines unit in 2007 KPIs and measurement results The most important KPI for this unit is the proportion of the number of finalised applications to the number of new, submitted applications, as a measure of the evolution of the unit’s backlog.
Some achievements and figures for the Veterinary Medicines unit in 2007 KPIs and measurement results The most important KPI for this unit is the proportion of the number of finalised applications to the number of new, submitted applications, as a measure of the evolution of the unit’s backlog.

This process includes data collection, monthly analysis of the results and discussion of the results and measures to be implemented with the wards involved.
Ce processus inclut la collecte de données, l'analyse mensuelle des résultats et la discussion des résultats et des mesures à mettre en œuvre avec les services des salles concernées.

The increased productivity is the result of concrete measures within the Registration department and has ensured that more MA are issued for medicines.
The increased productivity is the result of concrete measures within the Registration department and has ensured that more MA are issued for medicines.

As a result of the 37% decline in Alcon’s share price at the end of 2008 to USD 89.19 from the price paid for the initial 24.8% stake, Novartis performed an impairment test on the investment’s carrying value. This test assessed the “value in use” to Novartis of this strategic investment by valuing estimated discounted cash flows and future dividend streams from Alcon against the “fair value less costs to sell” of this stake, as measured by the closing price on December 31, 2008, on the NYSE for the 23% publicly traded Alcon shares.
Ce test consiste à comparer la « valeur d’utilité » de cet investissement stratégique pour Novartis sur la base d’une estimation des valeurs actualisées des flux de trésorerie futurs et des flux des dividendes futurs relatifs à la part détenue par Novartis avec la « juste valeur moins les coûts de la vente » sur la base du cours de clôture du 31 décembre 2008 des 23% d’actions Alcon négociées à la Bourse de New York.